An Liding ® Rebamipide Tablets
Category B under National Medical Insurance
[Drug Name]
Generic name: Rebapart Tablets
[Indications]
• Improvement of gastric mucosal lesions (erosion, bleeding, congestion, edema) in acute gastritis and acute exacerbations of chronic gastritis.
• Gastric ulcer.
[ Dosage and Administration ]
• For gastritis-related gastric mucosal lesions: usual adult dose is 0.1 g, three times daily, orally.
• For gastric ulcer: usual adult dose is 0.1 g, three times daily (morning, evening, and before bedtime), orally.
[ Contraindications ]
Contraindicated in patients with known hypersensitivity to this product.
[Specification]
0.1 g
[Shelf Life]
24 months
[Approval Number]
National Medical Products Administration Approval Number: H20243604
Hotline: 0591-83512959
Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063
Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.
